ORIFARM GROUP A/S: Financial statements 2016
CVR: 27347282
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ORIFARM GROUP A/S (CVR 27347282) has filed annual accounts for 2016. In 2016, the company reported revenue of EUR 8,786,000 and a net result of EUR 10,181,000 compared with EUR 9,120,000 the year before. That is a decrease of 10.6% compared with the year before. The profit margin was 115.9%. Equity in the 2016 report amounted to EUR 98,485,000. The solvency ratio was 54.5%. The company had 960 employees in the financial year.
- Revenue
- EUR 8,786,000
- Gross Profit
- EUR 8,842,000
- Profit/Loss
- EUR 10,181,000
- Equity
- EUR 98,485,000
- Total Assets
- EUR 180,841,000
- Employees
- 960
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 8.8 mio. EUR | 8.8 mio. EUR | 10.2 mio. EUR | 98.5 mio. EUR | 960 |
| 2015 | 9.8 mio. EUR | 9.8 mio. EUR | 9.1 mio. EUR | 90.3 mio. EUR | - |
| 2014 | 11.4 mio. EUR | 11.5 mio. EUR | 6.2 mio. EUR | 60.4 mio. EUR | - |
| 2013 | 11.9 mio. EUR | 11.9 mio. EUR | 6.2 mio. EUR | 55.8 mio. EUR | - |
Official annual report
Find more companies like ORIFARM GROUP A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of November 1, 2016, Ulrik Ernst Rasmussen is registered as director of ORIFARM GROUP A/S.
As of November 1, 2016, Jacob Lucassen is registered as director of ORIFARM GROUP A/S.
ORIFARM GROUP A/S has published its annual report for 2015. Revenue came to DKK 9,826,000, and the net result was DKK 9,120,000.
As of May 31, 2016, Jeanette Jæger Wallentin has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Christian Frederik Gyde Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Dan Kyster Hartwig has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Bettina Britt Juel Hansen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Søren Slott Sørensen has joined the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Søren Larsen has left the board of directors of ORIFARM GROUP A/S.
As of May 31, 2016, Karsten Dybmose Truelsen has left the board of directors of ORIFARM GROUP A/S.
About ORIFARM GROUP A/S
ORIFARM GROUP A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The company was previously named CAREFARM A/S. The management consists of Mads Fink Eriksen and Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Ole Michael Friis, Adeel Ahmad and Bettina Britt Juel Hansen. The company is owned by Orifarm Holding A/S. The company has 211 employees (2026). In 2025, the company reported a gross profit of EUR 1,478,000 and a net result of EUR 51,761,000 compared with EUR 3,260,000 the year before. Equity in the 2025 report amounted to EUR 413,677,000.